Risk stratification in non-ST elevation acute coronary syndromes: Predictive power of troponin I, C-reactive protein, fibrinogen and homocysteine

International Journal of Cardiology

Volumn 98, Issue 2, 2005, Pages 277-283

  Bodí, Vicent ^a   Sanchis, Juan ^a   Llàcer, Àngel ^a   Fácila, Lorenzo ^a   Núñez, Julio ^a   Bertomeu, Vicente ^a   Pellicer, Mauricio ^a   Chorro, Francisco J ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

C reactive protein; Myocardial infarction; Prognosis; Troponin; Unstable angina

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; FIBRINOGEN; HOMOCYSTEINE; TROPONIN I;

AGED; ARTICLE; CARDIOVASCULAR RISK; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NECROSIS; PRIORITY JOURNAL; PROGNOSIS; ST SEGMENT ELEVATION;

EID: 15944387712     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2003.10.046     Document Type: Article

References (33)

1. Hamm C.W. Cardiac biomarkers for rapid evaluation of chest pain. Circulation. 104:2001;1454-1456
2. Sabatine M.S., Morrow D.A., de Lemos J.A., et al. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes. Simultaneous assessment of troponin I, C-reactive protein and B-type natriuretic peptide. Circulation. 105:2002;1760-1763
3. Heidenreich P.A., Alloggiamento T., Melsop K., et al. The prognostic value of troponin in patients with non-ST elevation acute coronary syndromes: a meta-analysis. J. Am. Coll. Cardiol. 38:2001;478-485
4. Gibler W.B. Understanding true risk: evaluating troponins in the emergency setting. Am. Heart J. 137:1999;985-986
5. Goldman B.U., Christenson R.H., Hamm C.W., et al. Implications of troponin testing in clinical medicine. Curr. Control Trials Cardiovasc. Med. 2:2001;75-84
6. Ferreirós E.R., Boissonnet C.P., Pizarro R., et al. Independent prognostic value of elevated C-reactive protein in unstable angina. Circulation. 100:1999;1958-1963
7. Rader D.J. Inflammatory markers of coronary risk. N. Engl. J. Med. 343:2000;1179-1182
8. Lindahl B., Toss H., Siegbahn A., et al. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. N. Engl. J. Med. 343:2000;1139-1147
9. Toss H., Lindahl B., Siegbahn A., et al. Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable artery disease. Circulation. 96:1997;4204-4210
10. Mueller C., Buettner H.J., Hodgson J.M., et al. Inflammation and long-term mortality after non-ST elevation acute coronary syndrome treated with a very early invasive strategy in 1042 consecutive patients. Circulation. 105:2002;1412-1415
11. Bozkurt E., Erol M.K., Keles S., et al. Relation of plasma homocysteine levels to intracoronary thrombus in instable angina pectoris and in non-Q-wave acute myocardial infarction. Am. J. Cardiol. 90:2002;413-415
12. Schnyder G., Flammer Y., Roffi M., et al. Plasma homocysteine levels and late outcome after coronary angioplasty. J. Am. Coll. Cardiol. 40:2002;1769-1776
13. De Winter R.J., Fischer J., Bholasingh R., et al. C-reactive protein and cardiac troponin T in risk stratification: differences in optimal timing of tests early after the onset of chest pain. Clin. Chem. 46:2000;1597-1603
14. Joint European Society of Cardiology/American College of Cardiology Committee Myocardial infarction redefined. A consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur. Heart J. 21:2000;1502-1513
15. Cannon C.P., Weintraub W.S., Demopoulos L.A., et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N. Engl. J. Med. 344:2001;1879-1887
16. Lindahl B., Diderholm E., Lagerqvist B., et al. Mechanisms behind the prognostic value of troponin T in unstable coronary artery disease: a FRISC II substudy. J. Am. Coll. Cardiol. 38:2001;979-986
17. Jurlander B., Farhi E.R., Banas J.J., et al. Coronary angiographic findings and troponin T in patients with unstable angina pectoris. Am. J. Cardiol. 85:2000;810-814
18. Bodí V., Núñez J., Sanchis J., et al. Usefulness of troponin I to predict systolic dysfunction in acute coronary syndromes. Results of a prospective and quantitative study. Rev. Esp. Cardiol. S6:2003;738-741
19. Newby L.K., Storrow A.B., Gibler W.B., et al. Bedside multimarker testing for risk stratification in chest pain units: the chest pain evaluation by creatine kinase-MB, myoglobin and troponin I (CHECKMATE) study. Circulation. 103:2001;1832-1837
20. Sonel A., Sasseen B.M., Fineberg N., et al. Prospective study correlating fibrinopeptide A, troponin I, myoglobin, and myosin light chain levels with early and late ischemic events in consecutive patients presenting to the emergency department with chest pain. Circulation. 102:2000;1107-1113
21. Sanchis J., Bodí V., Llácer A. Usefulness of concomitant myoglobin and troponin elevation as biochemical marker of mortality in non-ST-segment elevation acute coronary syndromes. Am. J. Cardiol. 91:2003;13-16
22. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation. 104:2001;365-372
23. Libby P., Ridker P.M., Maseri A. Inflammation and atherosclerosis. Circulation. 105:2002;1135-1143
24. Bodí V., Fácila L., Sanchis J., et al. Short-term prognosis of patients admitted for probable acute coronary syndrome without ST-segment elevation. Role of new myocardial damage markers and acute-phase reactants. Rev. Esp. Cardiol. 55:2002;823-830
25. Bodí V., Núñez J., Sanchis J., et al. Why does C-reactive protein increase in non-ST elevation acute coronary síndromes? Role of myocardial damage. Int. J. Cardiol. 92:2003;129-135
26. Cusack M.R., Marber M.S., Lambiase, et al. Systemic inflammation in unstable angina is the result of myocardial necrosis. J. Am. Coll. Cardiol. 39:2002;1917-1923
27. Buffon A., Biasucci L.M., Liuzzo G., et al. Widespread coronary inflammation in unstable angina. N. Engl. J. Med. 347:2002;5-12
28. Schoenhagen P., Tuzcu E.M., Ellis S.G. Plaque vulnerability, plaque rupture and acute coronary syndromes. Multi-focal manifestation of a systemic disease process. Circulation. 106:2002;760-762
29. Verma S., Wang C.H., Li S.H. A self-fullfilling prophecy. C-reactive protein attenuates nitric oxide production and inhibit angiogenesis. Circulation. 106:2002;r28-r34
30. Fichtlscherer S., Zeiher A.M. Endothelial dysfunction in acute coronary syndromes: association with elevated C-reactive protein levels. Ann. Med. 32:2000;515-518
31. Kluft C. Is C-reactive protein an additional, surrogate endpoint for statin treatment? Eur. Heart J. 23:2002;761-764
32. Lamblin N., Bauters C., Helbecque N. Gene polymorphisms of pro- (or anti-) inflammatory cytokines and vascular disease. Eur. Heart J. 22:2001;2219-2220
33. Bhatt D.L., Topol E.J. Need to test the arterial inflammation hypothesis. Circulation. 106:2002;136-140